Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype
about
Confirmation of childhood acute lymphoblastic leukemia variants, ARID5B and IKZF1, and interaction with parental environmental exposuresRedefining ALL classification: toward detecting high-risk ALL and implementing precision medicineGenetic and nongenetic risk factors for childhood cancerChildhood Acute Lymphoblastic Leukemia: Progress Through CollaborationMeta-analysis of genome-wide association studies identifies multiple lung cancer susceptibility loci in never-smoking Asian womenThe 9p21.3 risk of childhood acute lymphoblastic leukaemia is explained by a rare high-impact variant in CDKN2ACommon germline variants within the CDKN2A/2B region affect risk of pancreatic neuroendocrine tumorsPolymorphic variation in TPMT is the principal determinant of TPMT phenotype: A meta-analysis of three genome-wide association studies.Large-Scale Exome-wide Association Analysis Identifies Loci for White Blood Cell Traits and Pleiotropy with Immune-Mediated Diseases.Differences in meiotic recombination rates in childhood acute lymphoblastic leukemia at an MHC class II hotspot close to disease associated haplotypes.Genomic ancestry and somatic alterations correlate with age at diagnosis in Hispanic children with B-cell acute lymphoblastic leukemiaRegulatory network of GATA3 in pediatric acute lymphoblastic leukemiaARID5B, IKZF1 and non-genetic factors in the etiology of childhood acute lymphoblastic leukemia: the ESCALE study.Inherited coding variants at the CDKN2A locus influence susceptibility to acute lymphoblastic leukaemia in children.Germline genetic variation in ETV6 and risk of childhood acute lymphoblastic leukaemia: a systematic genetic study.Association Between PIP4K2A Polymorphisms and Acute Lymphoblastic Leukemia Susceptibility.A genome-wide association study of susceptibility to acute lymphoblastic leukemia in adolescents and young adults.Common variation at 1q24.1 (ALDH9A1) is a potential risk factor for renal cancerAcute lymphoblastic leukemia in a 2-year-old girl whose mother was previously diagnosed with antiphospholipid syndrome: a case report.A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancerInherited genetic variation in childhood acute lymphoblastic leukemia.Somatic Mutation Allelic Ratio Test Using ddPCR (SMART-ddPCR): An Accurate Method for Assessment of Preferential Allelic Imbalance in Tumor DNA.Genetic and regulatory mechanism of susceptibility to high-hyperdiploid acute lymphoblastic leukaemia at 10p21.2.A Heritable Missense Polymorphism in CDKN2A Confers Strong Risk of Childhood Acute Lymphoblastic Leukemia and Is Preferentially Selected during Clonal Evolution.Confirmation of involvement of new variants at CDKN2A/B in pediatric acute lymphoblastic leukemia susceptibility in the Spanish populationA variant at 9p21.3 functionally implicates CDKN2B in paediatric B-cell precursor acute lymphoblastic leukaemia aetiology.Lineage-affiliated transcription factors bind the Gata3 Tce1 enhancer to mediate lineage-specific programs.A functional polymorphism in the CEBPE gene promoter influences acute lymphoblastic leukemia risk through interaction with the hematopoietic transcription factor Ikaros.A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1.Clonal and microclonal mutational heterogeneity in high hyperdiploid acute lymphoblastic leukemia.The role of KIR genes and their cognate HLA class I ligands in childhood acute lymphoblastic leukemia.Genomic and pharmacogenetic studies of childhood acute lymphoblastic leukemia.Genomics in acute lymphoblastic leukaemia: insights and treatment implications.Geographic/ethnic variability of chromosomal and molecular abnormalities in leukemia.A common genetic variation in CEBPE and acute lymphoblastic leukemia: a meta-analysis of the available evidence.Novel Gene and Network Associations Found for Acute Lymphoblastic Leukemia Using Case-Control and Family-Based Studies in Multiethnic Populations.Nuclear Phosphatidylinositol Signaling: Focus on Phosphatidylinositol Phosphate Kinases and Phospholipases C.Silencing of GATA3 defines a novel stem cell-like subgroup of ETP-ALL.A targeted knockdown screen of genes coding for phosphoinositide modulators identifies PIP4K2A as required for acute myeloid leukemia cell proliferation and survival.Childhood leukemia incidence in California: High and rising in the Hispanic population.
P2860
Q21131918-3FFCA219-5A51-451D-A1FB-EAF4B288876CQ26864460-7D66BE76-BAB3-4868-95FD-508A6A6B1FF4Q27693894-40CEF8AB-658C-4177-BC48-6270CC30DA95Q28087637-4C695FFD-4C01-4721-A81E-030B071DBB8DQ28385292-EF8D39C1-734B-4C1C-98EC-E3974651FA70Q28391081-9F948A64-A8A7-4F1D-BFA1-DA9D6F6C844AQ28397098-9F70C722-4BCB-488B-BC3D-455FD433D2C6Q30244222-6BDD12BA-DBA2-426A-A903-2C0380AEDF26Q30276495-23809D7A-CBE1-4272-BC83-7F74B7C8F9EAQ33800029-2BEE378A-B3D3-4969-BD6A-4707912E0955Q33801063-2DFB9E9E-C486-459B-A166-6C880C901B70Q33829399-510208BE-E2D8-40F8-BA83-6135845265E9Q34468538-0580204B-0930-4B9F-919E-B69C0B8165D4Q34482019-6FB4DBA9-908A-4D49-83F3-94AE6B5491B6Q34500075-04266118-B094-42AB-B2A4-2B9FC4439F01Q34525231-2C8A7F59-0750-49CC-BA55-47BA098C550EQ35004970-7FE19148-98DA-479E-A1C0-466DE7EF001DQ35235259-B3AD85A0-AD17-4362-9473-53E4DFC470B9Q35504270-B1E5E94F-2CC6-4E0D-8518-48BA3EB8C402Q35626744-D43C88C3-F7BD-4CE2-8730-DBF2820DBF66Q35784497-ED1D37E5-7A82-49E8-8F71-43D145C209D3Q35843497-FB3CEB14-9D25-48D5-8ACA-C7FB8BDA388BQ36296310-BC187EDD-B4E8-4819-B98D-C753C69947A4Q36296543-BCD5EFAC-A547-4DD8-8D9E-5D1F8FED5C94Q36365728-308800CD-A6CF-440A-992F-6FAA072DFCD4Q36582277-772E8BBA-FB60-4938-A613-A9C044DC5818Q36618547-74B55395-D6CC-44CA-9E57-5CB8EC1570B4Q36693283-396AC754-0FC6-41B1-9214-0685C878C40FQ37679670-2E7B750F-BCBA-486C-819C-5850689F8229Q37687285-088562E4-3F13-4998-A46C-E153A8508783Q37709339-39B2C730-48E1-4981-97F5-212E1EC46BAAQ38289596-F9E92EB2-84C9-4B85-9F19-12BA370E209DQ38381463-0D8CFB49-7EB0-4262-9FE9-A43C1A6281B9Q38554534-443145FA-8122-4424-BB21-A4C92E198C3DQ38590082-3868F5C0-6BF3-49AC-BD68-91C8DCD35BD6Q38650702-7996159E-C744-4574-8404-ABF2EAD9CECBQ38655657-22B36101-00FA-4E99-B6D5-2D7C6E860FC7Q38744314-C0258C42-8536-493F-ACDA-4BB7474A7204Q39010249-0B6515FE-B917-4A3F-A238-7DB061195E08Q39649538-0E231AC1-D322-4863-AC0D-33B7F7650CB9
P2860
Variation at 10p12.2 and 10p14 influences risk of childhood B-cell acute lymphoblastic leukemia and phenotype
description
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2013
@ast
im November 2013 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
wetenschappelijk artikel (gepubliceerd op 2013/11/07)
@nl
наукова стаття, опублікована в листопаді 2013
@uk
مقالة علمية (نشرت في 7-11-2013)
@ar
name
Variation at 10p12.2 and 10p14 ...... blastic leukemia and phenotype
@ast
Variation at 10p12.2 and 10p14 ...... blastic leukemia and phenotype
@en
Variation at 10p12.2 and 10p14 ...... blastic leukemia and phenotype
@en-gb
type
label
Variation at 10p12.2 and 10p14 ...... blastic leukemia and phenotype
@ast
Variation at 10p12.2 and 10p14 ...... blastic leukemia and phenotype
@en
Variation at 10p12.2 and 10p14 ...... blastic leukemia and phenotype
@en-gb
prefLabel
Variation at 10p12.2 and 10p14 ...... blastic leukemia and phenotype
@ast
Variation at 10p12.2 and 10p14 ...... blastic leukemia and phenotype
@en
Variation at 10p12.2 and 10p14 ...... blastic leukemia and phenotype
@en-gb
P2093
P50
P3181
P1433
P1476
Variation at 10p12.2 and 10p14 ...... blastic leukemia and phenotype
@en
P2093
Amy L. Sherborne
Bettina Fiege
Claus R. Bartram
Fay J. Hosking
Gabriele Migliorini
James M. Allan
Jayaram Vijayakrishnan
Julie A. Irving
Lewin Eisele
P304
P3181
P356
10.1182/BLOOD-2013-03-491316
P407
P50
P577
2013-11-07T00:00:00Z